ClinicalTrials HQ

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Recruiting · NCT05559164 · Registry updated 2025-11-14
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedCardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, cardiovascular disorder, heart disorder, injury, neoplasm, radiation injury, skin disorderRecruitingPhase 22025-11-14NCT05559164

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Rutgers, The State University of New Jersey154

10 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Monmouth Community MedicalLong BranchUnited States1
Monmouth Medical Center Southern CampusLakewoodUnited States37
Rutgers Cancer Institute of New JerseyNew BrunswickUnited States223
RWJBarnabas Health - - Jersey City Medical MedicalJersey CityUnited States1
RWJBarnabas Health - Monmouth Medical CenterLong BranchUnited States7
RWJBarnabas Health - Newark Beth Israel Medical CenterNewarkUnited States7
RWJBarnabas Health - Robert Wood Johnson University HospitalSomersetUnited States3
RWJBarnabas Health - Robert Wood Johnson University HospitalNew BrunswickUnited States5
RWJBarnabas Health - Robert Wood Johnson University Hospital, HamiltonHamiltonUnited States4
Trinitas Hospital and Comprehensive Cancer CenterElizabethUnited States5